Organs

DGAP-News: BRAIN AG publishes its Annual Report for the Financial Year 2019/20

Thursday, January 14, 2021 - 8:02am

Biotechnology Research and Information Network AG ("BRAIN AG") published its annual report 2019/20 including the detailed consolidated financial statements for the financial year 2019/20.

Key Points: 
  • Biotechnology Research and Information Network AG ("BRAIN AG") published its annual report 2019/20 including the detailed consolidated financial statements for the financial year 2019/20.
  • With liquid funds of EUR 18.9 million, BRAIN AG maintains a strong capital base for the expected future growth of the company.
  • Numerous factors exist that could influence the future performance by, and future developments at, BRAIN AG and the BRAIN Group.
  • BRAIN AG does not undertake any obligation to update or revise any forward-looking statements.

Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts

Wednesday, January 13, 2021 - 11:30am

In 2020, Zhongchao worked with medical associationsand experts to jointly carry out a multi-year online education project on the diagnosis and treatment of primary liver cancer.

Key Points: 
  • In 2020, Zhongchao worked with medical associationsand experts to jointly carry out a multi-year online education project on the diagnosis and treatment of primary liver cancer.
  • This project aims to promote and implement the Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2019 Edition) (the "Guidelines") published by the National Health Commission of the People's Republic of China.
  • The Annual Conference provided a timely platform for us to review last year's trainings on the standardized liver cancer diagnosis and treatment.
  • The Guidelines will undergo a new round of update in 2021 to meet the demand of rapid developments in liver cancer diagnosis and treatment in recent years.

Axcella Announces IND Clearance for AXA1665, Program Updates and 2021 Milestones

Monday, January 11, 2021 - 12:58pm

In the second quarter of 2021, Axcella plans to initiate a Phase 2 trial of AXA1665.

Key Points: 
  • In the second quarter of 2021, Axcella plans to initiate a Phase 2 trial of AXA1665.
  • The trial will be conducted globally with the primary endpoint assessing change in the psychometric hepatic encephalopathy score (PHES) after 24 weeks of treatment.
  • Based on the totality of the findings to date, Axcella has decided not to expand enrollment in the AXA4010-001 study.
  • Axcella plans to provide an update on its research and development activities and share details about opportunities it has identified for pipeline expansion later in 2021.

ProMind Complex Review: New Brain Boosting Supplement to Improve Memory

Monday, January 11, 2021 - 9:30am

The working of the ProMind Complex on the brain is quite complicated, primarily because of the brain's complexity.

Key Points: 
  • The working of the ProMind Complex on the brain is quite complicated, primarily because of the brain's complexity.
  • ProMind Complex optimizes the brain functions by activating all required brain pathways.
  • Unlike other nootropics that tend to have side effects on the brain, ProMind Complex is risk-free and safe for daily consumption.
  • In only a few years after its launch, ProMind Complex has already become a big name in the supplement industry .

ProMind Complex Review: New Brain Boosting Supplement to Improve Memory

Monday, January 11, 2021 - 9:30am

The working of the ProMind Complex on the brain is quite complicated, primarily because of the brain's complexity.

Key Points: 
  • The working of the ProMind Complex on the brain is quite complicated, primarily because of the brain's complexity.
  • ProMind Complex optimizes the brain functions by activating all required brain pathways.
  • Unlike other nootropics that tend to have side effects on the brain, ProMind Complex is risk-free and safe for daily consumption.
  • In only a few years after its launch, ProMind Complex has already become a big name in the supplement industry .

New on Public Television: The Brain Revolution

Monday, November 23, 2020 - 1:00pm

The program will delve into Dr. Merzenichs lifelong study of how to achieve and maintain a healthy and high performing brain.

Key Points: 
  • The program will delve into Dr. Merzenichs lifelong study of how to achieve and maintain a healthy and high performing brain.
  • At that time, their first such special, The Brain Fitness Program , became the most successful fundraiser in public television history.
  • His work showing the brain remains plastic overturned existing models about how the brain works and began a still unfolding revolution in our understanding of the brain.
  • Dr. Merzenich then pioneered how computers might be used to measure brain function, deliver the right stimuli in brain exercises, and drive the brain in a positive direction.

Merck Manuals Shares 5 Tips to Prevent and Reduce Heartburn

Thursday, November 19, 2020 - 3:00pm

Heartburn is a common symptom of gastroesophageal reflux disease (GERD), which develops when reflux of gastric contents in the esophagus causes troublesome symptoms and/or complications.

Key Points: 
  • Heartburn is a common symptom of gastroesophageal reflux disease (GERD), which develops when reflux of gastric contents in the esophagus causes troublesome symptoms and/or complications.
  • Dr. Lynch also shares five ways to reduce heartburn and GERD symptoms.
  • By four hours after a meal, around 90 percent of the food in your stomach has been digested.
  • Avoid lying down during that time including on the couch to help digestion and minimize heartburn.

MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020

Friday, November 13, 2020 - 3:00am

Specifically, the studies evaluated the effect of PDE4 inhibitors on attenuating fibrotic processes with an emphasis on HSC activation.

Key Points: 
  • Specifically, the studies evaluated the effect of PDE4 inhibitors on attenuating fibrotic processes with an emphasis on HSC activation.
  • Yuichi Iwaki, MD, PhD, President and Chief Executive Officer of MediciNova, Inc. commented, We are very pleased with the positive findings in an acute liver injury model study conducted by Dr. Gobejishvili and Dr. McClain.
  • We look forward to advancing to the next step to further investigate the potential of MN-001 in liver fibrosis.
  • The attenuation of TGF1 signaling for HSC activation and the anti-fibrogenic effect in an acute liver injury model by MN-001 was very promising.

Global Cardiac Mapping Market Report 2020-2025

Tuesday, November 10, 2020 - 1:45pm

DUBLIN, Nov. 10, 2020 /PRNewswire/ -- The "Global Cardiac Mapping Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 10, 2020 /PRNewswire/ -- The "Global Cardiac Mapping Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The factors such as increasing incidence of cardiovascular diseases is expected to propel the cardiac mapping market.
  • However, the lack of skilled & experienced electrophysiologists along with the costs associated with the cardiac mapping procedure may restrain the market to an extent during the forecast period.
  • The Global Cardiac Imaging Market can be segmented on the basis of technology, end user, indication and geography.

LearningRx® Brain Training Centers Partner with Award-Winning Children's Author

Thursday, November 5, 2020 - 1:38pm

COLORADO SPRINGS, Colo., Nov. 5, 2020 /PRNewswire/ --LearningRx, the world's largest personal brain training company, has partnered with an award-winning author to launch a new book that helps students overcome learning (and life!)

Key Points: 
  • COLORADO SPRINGS, Colo., Nov. 5, 2020 /PRNewswire/ --LearningRx, the world's largest personal brain training company, has partnered with an award-winning author to launch a new book that helps students overcome learning (and life!)
  • "Our 109,000+ clients have experienced life-changing results from one-on-one personal brain training, which not only yielded stronger brain skills, but also a huge boost in our graduates' confidence.
  • LearningRx Marketing & Media Relations Director Lisa Juhl is available for interviews and can discuss:
    How brain training has helped more than 100,000 LearningRx graduates learn easier, think faster, and perform better
    Brain training programs available for people with ADHD/attention issues, reading/dyslexia challenges, memory decline, learning differences, and more
    LearningRx, headquartered in Colorado Springs, Colorado, is the largest one-on-one brain training company in the world.
  • To learn more visit https://www.learningrx.com
    LearningRx Brain Training | Colorado Springs, CO | 719.660.5312 | 258046@email4pr.com
    View original content to download multimedia: http://www.prnewswire.com/news-releases/learningrx-brain-training-center...